Evaluation of changes in biologic markers ER, PR, HER 2 and Ki-67 index in breast cancer with administration of neoadjuvant dose dense doxorubicin, cyclophosphamide followed by paclitaxel chemotherary
JOURNAL OF BUON, cilt.18, sa.2, ss.366-371, 2013 (SCI İndekslerine Giren Dergi)
Makale / Tam Makale
JOURNAL OF BUON
Purpose: The aim of this study was to assess the changes in biologic markers of breast cancer ER, PR, HER 2 and Ki-67 in locally advanced breast cancer patients after neoadjuvant chemotherapy.